AliveCor, Inc. is transforming cardiological care using deep learning. The FDA-cleared KardiaMobile device is the most clinically-validated personal ECG solution in the world. KardiaMobile 6L provides instant detection of Atrial Fibrillation, Bradycardia, Tachycardia, Sinus Rhythm with Supraventricular Ectopy, Sinus Rhythm with Premature Ventricular Contractions, Sinus Rhythm with Wide QRS, and Normal Sinus Rhythm in an ECG. Kardia is the first AI-enabled platform to aid patients and clinicians in the efficient detection of atrial fibrillation, the most common arrhythmia and one associated with a highly-elevated risk of stroke. AliveCor's enterprise platform allows third-party providers to manage their patients’ and customers’ heart conditions simply using state-of-the-art tools that provide easy front-end and back-end integration to AliveCor technologies. AliveCor protects its customers with stringent data security and compliance practices, achieving ISO 27001 Certification, SOC 2 Type 2 Certification and HIPAA compliance attestation. AliveCor is a privately-held company headquartered in Mountain View, Calif. “Consumer” or “Personal” ECGs are ECG devices available for direct sale to consumers. For more information, visit alivecor.com.
Psychemedics develops and delivers the world’s leading hair drug test for detecting drugs of abuse. Some of the most well-known companies in the Fortune 500, largest police departments, and schools across the country use Psychemedics’ patented drug tests using hair to ensure safer workplaces and campuses. After 30 years, the company remains the drug testing industry’s leading innovator and consistently advances the science of hair testing for drugs of abuse.
Employing the leading scientists in the field of drug detection science, Psychemedics protects businesses by identifying more drug users for more companies than any other hair testing laboratory in the world. Unique among laboratories, all Psychemedics drug screens are FDA 510k approved. Those tests include the 5 panel drug test and additional tests for emerging threats like fentanyl and benzodiazepines.
For more information, visit the Psychemedics website at www.psychemedics.com
For more information, visit the Psychemedics website at www.psychemedics.com
BrainCo’s leadership draws on deep experience in neuroscience research and expertise in education to deliver entirely new applications of brainwave technology in the education, wellness, and research spaces. We’ve learned important lessons as we’ve grown from a small team in an apartment basement to over 100 employees in 4 offices around the world. Since 2015 we’ve been working on providing the best experience possible for our customers and we’re here to share our progress and innovations with you.